MedTrace Logo

Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity

NCT02148562 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 274

Last updated 2014-05-28

No results posted yet for this study

Summary

In this project proposal, the investigators will investigate the genetic alterations of Hepatitis B Virus (HBV) strains circulating in Belgian patients who developed end stage liver disease. Additionally, the investigators will compare and link these data sets with three genetic factors involved in immune system response.

Conditions

  • Hepatitis B
  • Hepatitis B, Chronic
  • End Stage Liver Disease
  • Carcinoma, Hepatocellular

Sponsors & Collaborators

  • Fund for Scientific Research, Flanders, Belgium

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • MahmoudReza Pourkarim, PhD · UZ Leuven campus Gasthuisberg, Herestraat 49. 3000 Leuven, Belgium

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02148562 on ClinicalTrials.gov